A regulatory take on cannabis and cannabinoids for medicinal use in the European Union
The discovery of the endocannabinoid system has raised public interest in the medicinal use of cannabis, phytocannabinoids, and synthetic cannabinoids, which has always been closely regulated due to their psychotropic effects and potential abuse. The review takes a quick look at the current legal fr...
Main Authors: | Lipnik-Štangelj Metoda, Razinger Barbara |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2020-03-01
|
Series: | Arhiv za Higijenu Rada i Toksikologiju |
Subjects: | |
Online Access: | https://doi.org/10.2478/aiht-2020-71-3302 |
Similar Items
-
Raba konoplje v medicinske namene
by: Armin Čulić, et al.
Published: (2021-12-01) -
Problematika terminov "prostoživeče", "gojene" in "rejne" živali v slovenski zakonodaji
by: Aleksandra ŽIGO JONOZOVIČ
Published: (2007-12-01) -
A Review on the Bioactivity of Cannabinoids on Zebrafish Models: Emphasis on Neurodevelopment
by: Rosario Licitra, et al.
Published: (2022-07-01) -
“The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
by: Mona Khoury, et al.
Published: (2022-02-01) -
Simultaneous Quantification of 17 Cannabinoids in Cannabis Inflorescence by Liquid Chromatography-Mass Spectrometry
by: Amitha K. Hewavitharana, et al.
Published: (2022-03-01)